{"nct_id":"NCT00113048","title":"Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies","status":"TERMINATED","status_verified_date":"2014-02","start_date":"2003-12","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2005-09","completion_date_type":null,"phases":["PHASE1"],"tickers":["SNY"]}